Benjamin F. Edwards & Company’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $154K | Buy |
745
+50
| +7% | +$10.3K | ﹤0.01% | 981 |
|
|
2024
Q1 | $188K | Sell |
695
-62
| -8% | -$16.8K | ﹤0.01% | 926 |
|
|
2023
Q4 | $179K | Buy |
757
+625
| +473% | +$148K | ﹤0.01% | 904 |
|
|
2023
Q3 | $26K | Buy |
132
+66
| +100% | +$13K | ﹤0.01% | 1196 |
|
|
2023
Q2 | $14K | Hold |
66
| – | – | ﹤0.01% | 1347 |
|
|
2023
Q1 | $13K | Sell |
66
-1
| -1% | -$197 | ﹤0.01% | 1351 |
|
|
2022
Q4 | $15K | Buy |
67
+41
| +158% | +$9.18K | ﹤0.01% | 1336 |
|
|
2022
Q3 | $5K | Buy |
+26
| New | +$5K | ﹤0.01% | 1542 |
|
|
2021
Q2 | – | Sell |
-60
| Closed | -$17K | – | 1692 |
|
|
2021
Q1 | $17K | Buy |
+60
| New | +$17K | ﹤0.01% | 1237 |
|
|
2019
Q3 | – | Sell |
-100
| Closed | -$14K | – | 1843 |
|
|
2019
Q2 | $14K | Hold |
100
| – | – | ﹤0.01% | 1304 |
|
|
2019
Q1 | $15K | Buy |
+100
| New | +$15K | ﹤0.01% | 1208 |
|